Iris Ziekenhuizen Zuid is een samenwerking van vier ziekenhuizen in Brussel. Deze organisatie is in 1999 ontstaan uit een fusie van vier verpleegcentra in het zuiden van Brussel: Baron Lambert, Elsene, Joseph Bracops en Molière Longchamp.

During the past decade, Hopitaux IRIS Sud conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopitaux IRIS Sud" #1 sponsor was "European Lung Cancer Working Party" with 2 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Agennix" with 1 trials sponsored, "Asahi Kasei Pharma America Corporation" with 1 trials sponsored and "Avexa" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopitaux IRIS Sud" #1 collaborator was "Centre Hospitalier Universitaire Brugmann" with 1 trials as a collaborator, "Erasme University Hospital" with 1 trials as a collaborator, "Hôpitaux IRIS Sud" with 1 trials as a collaborator, "Jules Bordet Institute" with 1 trials as a collaborator and "NOVAVISION GROUP S.P.A" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hopitaux IRIS Sud" are "HIV Infections" (3 trials), "Acquired Immunodeficiency Syndrome" (2 trials), "Severe Sepsis" (2 trials), "Coagulopathy" (1 trials) and "Genitourinary Syndrome of Menopause" (1 trials). Many other conditions were trialed in "Hopitaux IRIS Sud" in a lesser frequency.

Most popular intervention types in "Hopitaux IRIS Sud" are "Drug" (8 trials), "Device" (1 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "FTC/TDF" (2 trials), "Placebo" (2 trials), "ART-123" (1 trials), "ATV" (1 trials) and "ATV Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopitaux IRIS Sud" are 7 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hopitaux IRIS Sud". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hopitaux IRIS Sud, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hopitaux IRIS Sud, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".